NFKB1 and pulmonary fibrosis: The protective effects of EGCG are related to preventing cytokine storm-associated acute lung injury/acute respiratory distress syndrome, thrombosis by inhibiting tissue factors and activating platelets, sepsis by inactivating redox-sensitive high mobility group box 1 (HMGB1), and lung fibrosis via increasing Nrf2 and hindering NF-κB activation [136].